2023-01-09 - Cancer Synoptic Reporting Project Group Meeting

2023-01-09 - Cancer Synoptic Reporting Project Group Meeting

Cancer Synoptic Reporting Project Group

9-January-2023 at 15:30 - 16:30 UTC

Attendees 

@Scott Campbell @Jieun Hwang  dubois  @Laszlo Igali @Jim Case  @brianrous @Nicola Ingram @rosssimpson @Thomas Ruediger @kerenhulkower  @Suzanne Santamaria @ericdaley @Keng-Ling Wallin @Elaine Wooler @Ekaterina Bazyleva 



Discussion items

Item

Description

Owner

Notes

Action

Item

Description

Owner

Notes

Action

1

Record meeting

@Scott Campbell 





 Cannot do!  Not a host Done!!

2

Closing gaps in content - dysplasia and neoplasia at margins

@Scott Campbell 

  1. Need references


  2. Questions:

    1. When is a #plasia generalized vs. localized (i.e., by organ)





  1. Definitions of high-grade/low-grade glandular dysplasia

  2. Definitions of high-grade/low-grade glandular intraepithelial neoplasia

  3. Definitions of high-grade/low-grade squamous intraepithelial neoplasia

  4. Sample of observable entity concepts created

Observable entity concepts are fine.  @Jim Case asked for documentation on the *plasias and High-/Low- grading definitions as supporting documentation for ongoing use

@Scott Campbell will draft a "blurb" and pathologists on the call will provide appropriate citations.



1/9/2023 - HG dysplasia vs. CIS.

Discussed the use of HG dysplasia, carcinoma in situ (CIS), and the and/or version.  This needs to be reviewed as the and/or for lymphovascular invasion body structure does not look correct for subsumption and classification.  GCIs may not be possible as they need defining attributes.


RE: #plasias.  @Thomas Ruediger  supports a single set of morphologic abnormality concepts for glandular dysplasia, glandular intraepithelial neoplasia, squamous dysplasia, intraepithelial squamous neoplasia that are completely organ agnostic.

@ stefandubois suggests that such a conflation of concepts will require a comprehensive review by organ system.

In my opinion, both are correct.  This dovetails nicely into the Histology QI project.

The CSRWG needs to address what needs to/can be done to get the synoptic reporting content deliverable in the shorter term while also addressing the longer term Histology QI issue.

3

Missing body structures

@Scott Campbell 

  1. Async?  Out of sync

Not discussed


4

Wilms tumor/nephroblastoma NICTIZ

@Scott Campbell 

  1. requests from Elze de Groot

@Scott Campbell to follow up.  @Paul forwarded protocolSIOP-F4.pdf

@Scott Campbell meeting with Nictiz on Friday, 1/16/23

5

GU histologies

@Scott Campbell 

  1. Looking for interested parties

@stefan dubois; @brian rous; @ross simpson will assist.  @Scott Campbell will get meetings started.

6

Follow up on protocol review by authoritative bodies

@Scott Campbell 

  1. Documents of SNOMED CT terminology binding across major protocol producers

@Scott Campbell will forward marked up ICCR, RCPath protocols to team for review of SNOMED CT content bindings.


  1. ICCR

  2. CAP

Needs to be followed up in another meeting.

8

Business meeting

@Scott Campbell 

  1. In person/mixed

2 > half days; Also pathology CRG will meet f2f

Meeting Files







Previous Meetings

Copyright © 2025, SNOMED International